发明名称 Vaccine composition comprising an antigen and a peptide having adjuvant properties
摘要 The invention relates to a vaccine which comprises at least one antigen and a peptide comprising a sequence R1—XZXZNXZX—R2, whereby N is a whole number between 3 and 7, preferably 5, X is a positively charged natural and/or non-natural amino acid residue, Z is an amino acid residue selected from the group consisting of L, V, I, F and/or W, and R1 and R2 are selected independently one from the other from the group consisting of —H, —NH2, —COCH3, —COH, a peptide with up to 20 amino acid residues or a peptide reactive group or a peptide linker with or without a peptide; X—R2 may also be an amide, ester or thioester of the C-terminal amino acid residue, as well as the use of said peptide for enhancing a patient's adaptive immune response to an antigen.
申请公布号 US8900564(B2) 申请公布日期 2014.12.02
申请号 US200812124785 申请日期 2008.05.21
申请人 Valneva Austria GmbH 发明人 Fritz Jörg;Mattner Frank;Zauner Wolfgang;Nagy Eszter;Buschle Michael
分类号 A61K38/00;A61K38/04;A61K38/08;A61K38/27;A61K39/00;A61K45/00;A61K48/00;C07K7/06;A61K39/39;C07K4/00 主分类号 A61K38/00
代理机构 Wolf, Greenfield & Sacks, P.C. 代理人 Wolf, Greenfield & Sacks, P.C.
主权项 1. A method of enhancing a patient's adaptive immune response to an antigen comprising: obtaining at least one antigen; obtaining at least one peptide comprising a sequence H-KLKLLLLLKLK-H (SEQ ID NO:1; and administering the antigen and the peptide to a patient.
地址 Vienna AT